US Stock MarketDetailed Quotes

ImmuCell (ICCC)

Watchlist
  • 6.370
  • -0.260-3.92%
Close Mar 13 16:00 ET
57.62MMarket Cap-53.08P/E (TTM)

ImmuCell (ICCC) Key Financial Indicators

ICCC Earnings per Share (EPS)

According to the latest financial report of ImmuCell, the latest earnings per share (TTM) for the company is -0.31. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

ICCC Free Cash Flow (FCF)

Interested in knowing about ImmuCell's free cash flow? The latest report shows it as 1.56M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

ICCC Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ImmuCell shows that the company's current ratio is 4.21, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

ICCC Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ImmuCell, the quick ratio is 1.62, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ICCC Return on Equity (ROE)

Want to learn more about the financial health of ImmuCell? The latest ROE figure is -10.02%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ICCC Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ImmuCell, the total asset return on investment (ROA) is -6.46%.

Currency: USD

Quarterly

Loading...

ICCC Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check ImmuCell's latest financial report to see how their gross margin is doing - currently at 38.16%.

Currency: USD

Quarterly

Loading...

ICCC Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ImmuCell, the net profit margin is -37.36%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. Over the weekend, the situation in the Mid Show More